Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
您搜索 "法国诗华，金宇保灵，合资公司，布鲁氏菌病" 回到 63 结果。
诗华在载体和免疫复合物疫苗技术方面处于世界领先地位。世界上超过25%的肉鸡使用诗华新技术疫苗免疫。诗华在免疫复合物疫苗和载体疫苗技术方面处于世界领先，在世界各地拥有七家研发生产中心。
通过提供全套的创新疫苗、设备和服务，保证安全有效的免疫，诗华谨遵“护佑健康，与您同行”的使命，帮助家禽生产高效且可持续发展。诗华在全球推出的C计划，帮助客户在孵化场完成免疫接种工作，确保了孵化场免疫质量。
作为全球领先和历史最为悠久的动物保健企业之一，诗华总部位于法国，自成立以来，我公司获得了巨大的成功和发展, 已连续5年成为成长最快的世界动物保健品公司之一。
返回顶部